Please wait while we open this resource.
K
Guidelines & protocols
USE OF LIOTHYRONINE (T3) IN HYPOTHYROIDISM: JOINT BRITISH THYROID ASSOCIATION/SOCIETY FOR ENDOCRINOLOGY CONSENSUS STATEMENT
Norfolk and Norwich University Hospitals NHS Trust, University College London, and other affiliated institutions
PDF202311 pages1.0 MB
Persistent symptoms in patients treated for hypothyroidism are common, and the use of liothyronine remains controversial. This document aims to provide evidence-based recommendations for clinicians managing such patients, particularly within the UK National Health Service. It addresses the diagnosis of overt hypothyroidism and outlines key clinical practice points for the use of liothyronine in treatment regimens.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology
Kiruddu DKA guidelines
Same clinical topic · Endocrinology
Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology
Management of DKA
Same clinical topic · Endocrinology
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology
GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology
2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology
CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology
Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology